Patients saddled with large amounts of medical debt often don’t pay up: Healthcare providers’ collection rates could continue to worsen. We detail the reasons why—and explore how they can improve.
Virta Health’s approach to lower-cost weight loss should please employers, health plans: People who stopped taking expensive weight-loss drugs but stuck with a low-carb diet kept the weight off, a new study shows.
D2C pharmacies face challenges stocking costly drugs: But a new study suggests Amazon Pharmacy has an advantage over rivals.
Lots of consumers are self-medicating: A new survey discloses the many reasons patients give for taking meds without a doc’s supervision. Marketers must pay closer attention to the worrisome trends of self-medication and self-diagnosis.
Independent pharmacies are getting squeezed: Facing financial pressure, a third of community pharmacies say they’re considering closing down. We look at what this means for patients and the industry.
UnitedHealth Group is facing an antitrust investigation: The probe could rein in the most dominant US healthcare company.
Vale Health’s new online marketplace vets health and wellness solutions for patients: Healthcare brands with products on the platform could see increased sales—here’s why.
Pharma is moving slowly on AI adoption: A new survey shows the drug industry’s tentative approach to AI tech. We unpack the reasons for this lag and show where AI will be put to work—from marketing to clinical trials.
Health system CEOs tackle gun violence: We explore how healthcare marketers and providers can work together on educating patients about gun violence prevention and safety.
Americans are coming around to weight loss drugs: Pharma has done a good job abating stigmas around the drugs with ads. Now, more companies want a piece of the GLP-1 pie.
Personalized healthcare drives growth for Hims & Hers: AI is helping the company’s providers customize treatments for patients. If the strategy pays off, Hims & Hers may soon leave its competition in the dust.
Hackers took down a crucial piece of US healthcare payments infrastructure: UnitedHealth’s Change Healthcare still hasn’t recovered, leaving providers unpaid and people unable to get care. It’s an unwelcome reminder of how vulnerable the system is to disruption.
Where do consumers want to see prescription drug ads? They trust doctor’s offices the most. But we explain why pharma marketers won’t be deterred from advertising more on digital channels.
Walgreens is closing 50+ medical clinics in Florida: The retailer is rethinking its care delivery strategy to stem losses under a new CEO.
Health systems want to up their use of AI: But a new survey reveals a crucial internal challenge they need to overcome before they make big AI investments.
BetterHelp’s flat revenues are thanks to lower yield on social ad spending: D2C digital health companies need to advertise more ethically on social media amid increased scrutiny from regulators.
US senators ask FDA to clamp down on Rx social media ads: We unpack the lawmakers’ requests and explore how prescription drug companies and telehealth players must bear more responsibility for their social media ads.
Healthcare affordability is top of mind for US voters: Democrats and Republicans are aligned about high healthcare costs. We explore what it means for marketers during this election season.
GLP-1 medication users spend less money on groceries: The likes of Ozempic and Wegovy are reshaping consumer spending patterns. We explore how grocers and food companies must adapt.
More consumers turn to digital tools for Rx management: But increased demand for online pharmacy services could actually spell trouble for pharmacy disruptors—here’s why.